Evaluation of UHRF1 and P16INK4A expression levels in newly diagnosed AML patients
Open Access
- 21 September 2018
- journal article
- research article
- Published by Biomedical Research and Therapy in Biomedical Research and Therapy
- Vol. 5 (9), 2658-2663
- https://doi.org/10.15419/bmrat.v5i9.475
Abstract
Introduction: Gene mutation is an infrequent cause of tumor suppressor gene (TSG) defect in de novo AML patients. Instead, it seems that leukemic cells employ epigenetic tricks to attenuate the negative impacts of intact TSGs. Ordinarily, critical TSGs, such as p16INK4A, is hyper-methylated in AML blasts under the impact of master epigenetic regulators, such as UHRF1. In this study, we investigated the correlation between UHRF1 and p16INK4A gene expression levels in newly diagnosed AML patients. Methods: Bone marrow and peripheral blood samples were obtained from 50 newly diagnosed AML patients and 18 healthy normal control subjects. Gene expression levels of UHRF1 and P16INK4A were surveyed using SYBR Green Quantitative Real-time PCR. Statistical analyses were done using SPSS statistical software 21.0. Results: P16INK4A gene expression showed reduced levels in 80.64% of patients above 45 years of age, while only 32% of patients below 45 years had reduced expression levels. The Spearman correlation test also demonstrated a significant negative correlation between UHRF1 and p16INK4A gene expression levels in AML patients, which was not observed in the control group (r=0.343 and P= 0.015). Conclusion: Regarding the age-related patterns of UHRF1 and p16INK4A gene expression, and also the presence of negative correlation between them, we conclude that UHRF1 may potentially be involved in p16INK4A down-regulation in elderly AML patients, which may subsequently facilitate the progression of AML in older ages.Keywords
This publication has 27 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaThe New England Journal of Medicine, 2013
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaThe New England Journal of Medicine, 2012
- The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progressionOncogene, 2012
- UHRF1 Promotes Cell Growth and Metastasis Through Repression of p16ink4a in Colorectal CancerAnnals of Surgical Oncology, 2012
- Genetic and epigenetic similarities and differences between childhood and adult AMLPediatric Blood & Cancer, 2011
- AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significanceBlood, 2009
- The Regulation of INK4/ARF in Cancer and AgingCell, 2006
- Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemiaLeukemia, 2004
- DNA methylation and gene silencing in cancer: which is the guilty party?Oncogene, 2002